Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Innovative Industrial Properties Secures $100M Credit Facility

Innovative Industrial Properties, Inc. (NYSE: IIPR) has just closed on a new $100 million secured revolving credit facility with a federally regulated commercial bank. The credit facility has an initial term of 3 years and is secured by the company’s IQHQ investment. Borrowings under the credit facility will bear interest at a rate equal to the one-month secured overnight financing rate (SOFR) plus a spread of 200 basis points (6.1% based on rates as of October 3, 2025). The credit facility also includes a $35 million “accordion feature” that permits the company to expand the borrowing capacity to a total of $135 million, subject to the addition of other lenders.

Alan Gold, Executive Chairman of IIP, noted that the successful closing of this credit facility supports their thesis that the recent investment in the life science industry should lead to improved access to and lower cost of capital. He highlighted the strong, low leveraged balance sheet and stated that the credit facility enhances their financial flexibility and provides them with an attractive, accretive investment spread exceeding 800 basis points on their IQHQ investment.

Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership, and management of specialized industrial properties and life science real estate.

This announcement comes as the company continues to capitalize on the strength of the life science industry, and with this new credit facility in place, it is well-positioned to support its strategic growth initiatives. Today the company's shares have moved -0.82% to a price of $54.41. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS